Reading view

Programming biology: next-gen AI firms raise billions to design better medicines

26 May 2026 at 08:00

Nature Biotechnology, Published online: 26 May 2026; doi:10.1038/s41587-026-03170-9

Faster drug discovery, optimized drug design, even programmable therapeutics: AI is impacting R&D. Data and development bottlenecks remain.

10 March 2026 at 08:00

Nature Biotechnology, Published online: 10 March 2026; doi:10.1038/s41587-026-03069-5

Deep B cell depletion is delivering transformative clinical results in autoimmune diseases. Dealmakers are wagering on the best tools for the job.